Concepedia

Myra M. Mizokami

MM

6

Publications

261

Citations

6

H-Index

1998

Active since

Affiliations

University of Southern California(Current)

Myra M. Mizokami is an author at University of Southern California specializing in immunotherapy, tumor microenvironment, and immunology.

Top concepts

Publications per year

1998–2003

6

Publications

6

A New Chemically Modified Chimeric TNT-3 Monoclonal Antibody Directed Against DNA for the Radioimmunotherapy of Solid Tumors

Jason L. Hornick, Jahangir Sharifi, Leslie A. Khawli et al. · Cancer Biotherapy and Radiopharmaceuticals · 1998 · 61 citations

, , +17

Identification of a Protein Fragment of Interleukin 2 Responsible for Vasopermeability

Alan L. Epstein, Myra M. Mizokami, Jun Li et al. · JNCI Journal of the National Cancer Institute · 2003 · 45 citations · Full text

Pharmacokinetic Characteristics and Biodistribution of Radioiodinated Chimeric TNT-1, -2, and -3 Monoclonal Antibodies After Chemical Modification with Biotin

Leslie A. Khawli, Myra M. Mizokami, Jahangir Sharifi et al. · Cancer Biotherapy and Radiopharmaceuticals · 2002 · 44 citations

, , +19

Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity

Peisheng Hu, Myra M. Mizokami, Gina Ruoff et al. · Blood · 2003 · 42 citations · Full text

Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors.

Jason L. Hornick, Jahangir Sharifi, Leslie A. Khawli et al. · PubMed · 2000 · 39 citations

Rows per page

1–5 of 6